Armodafinil (Nuvigil) Prior Authorization
Customize your policy alerts
Sign up for all venturacountyhealthcareplan policy alerts
Know when venturacountyhealthcareplan releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization for armodafinil (Nuvigil) used to promote wakefulness in members with narcolepsy, obstructive sleep apnea/hypopnea syndrome, or shift-work disorder. Providers must submit diagnostic confirmation and, when applicable, documentation of prior positive-airway-pressure treatment and ongoing symptoms.
The February 18, 2025 revision updated the armodafinil definition and precautions section.
The February 18, 2025 revision added references addressing pregnancy outcomes and serious cutaneous reactions associated with armodafinil or modafinil.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.